Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

Lykke Sylow; Mia Klinten Grand; Annika von Heymann; Frederik Persson; Volkert Siersma; Margit Kriegbaum; Christen Lykkegaard Andersen; Christoffer Johansen

doi:10.2337/dc22-0232

Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

Lykke Sylow^*, Mia Klinten Grand, Annika von Heymann, Frederik Persson, Volkert Siersma, Margit Kriegbaum, Christen Lykkegaard Andersen, Christoffer Johansen

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

12 Citations (Scopus)

36 Downloads (Pure)

Abstract

For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer on
overall survival.

Original language	English
Journal	Diabetes Care
Volume	45
Issue number	6
Pages (from-to)	e105-e106
Number of pages	2
ISSN	1935-5548
DOIs	https://doi.org/10.2337/dc22-0232
Publication status	Published - 2022

Access to Document

10.2337/dc22-0232Licence: Unspecified

Sylow et al_Diabetes Care_2022_Vol 45(6)_e105-e106Final published version, 3.09 MBLicence: Unspecified

Cite this

@article{4fa60bfaafd8466c8aa8ed08ed8005bf,

title = "Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study",

abstract = "For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.",

author = "Lykke Sylow and Grand, {Mia Klinten} and {von Heymann}, Annika and Frederik Persson and Volkert Siersma and Margit Kriegbaum and {Lykkegaard Andersen}, Christen and Christoffer Johansen",

note = "CURIS 2022 NEXS 144",

year = "2022",

doi = "10.2337/dc22-0232",

language = "English",

volume = "45",

pages = "e105--e106",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association",

number = "6",

}

TY - JOUR

T1 - Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

AU - Sylow, Lykke

AU - Grand, Mia Klinten

AU - von Heymann, Annika

AU - Persson, Frederik

AU - Siersma, Volkert

AU - Kriegbaum, Margit

AU - Lykkegaard Andersen, Christen

AU - Johansen, Christoffer

N1 - CURIS 2022 NEXS 144

PY - 2022

Y1 - 2022

N2 - For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.

AB - For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.

U2 - 10.2337/dc22-0232

DO - 10.2337/dc22-0232

M3 - Letter

C2 - 35653597

SN - 1935-5548

VL - 45

SP - e105-e106

JO - Diabetes Care

JF - Diabetes Care

IS - 6

ER -